The Parliament of Cyprus has recently enacted significant new regulations aimed at enhancing patient safety within diagnostic imaging facilities. Simultaneously, lawmakers are preparing to implement stringent controls over the rapidly expanding market of nicotine pouches, demonstrating a clear commitment to public health. These decisive actions emerged from recent parliamentary sessions and thorough committee discussions.
During a session on Thursday, parliamentarians unanimously approved legislation requiring a qualified radiologist to be physically present during all diagnostic imaging examinations. This crucial amendment, supported by several major political parties, clarifies a long-standing ambiguity and reaffirms the essential role of specialist physicians in interpreting medical scans. Furthermore, the new law explicitly prohibits the provision of animal diagnostic services in facilities intended for human patients. Veterinary imaging services will now be restricted to specialized establishments, ensuring a distinct separation between human and animal healthcare.
These new regulations will have immediate and considerable effects on radiology centres, compelling them to guarantee a certified radiologist's on-site supervision of all imaging procedures. This measure is expected to improve the accuracy and reliability of diagnostic outcomes for patients. The segregation of animal imaging services is also anticipated to enhance operational efficiency and potentially raise care standards in both sectors.
In parallel, the parliamentary Health Committee has reached a consensus on a bill that will bring nicotine pouches under existing tobacco control legislation. This proposed amendment to the health protection and smoking control law aims to classify these tobacco-free, orally consumed products as regulated items, similar to traditional tobacco products. The committee’s comprehensive deliberations involved extensive consultations with key stakeholders, including licensed importers, distributors, and retail representatives.
The proposed definition for a nicotine pouch describes an industrially manufactured, non-inhaled product containing nicotine, typically in a solid form and intended for oral use. This definition specifically excludes medical or pharmaceutical products. Licensed importers and distributors have themselves advocated for robust oversight, proposing mandatory health warnings, detailed product information, and child-resistant packaging.
A formal vote on the nicotine pouch regulation is expected before the end of March, with the Health Committee expressing strong confidence in its enactment. This proactive stance reflects a growing awareness of nicotine pouches as a product requiring careful management, particularly regarding accessibility and potential public health consequences. The impending regulations are intended to align the sale and marketing of nicotine pouches with those of other nicotine-containing products, establishing a more consistent regulatory framework throughout Cyprus.